A method for treating a human infected with by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by in an immuno-compromised host being treated with a bone marrow transplantation.Guido Rasi...
Basilea Pharmaceutica Ltd announced that it has entered into an asset purchase agreement with privately owned Gravitas Therapeutics Inc. for GR-2397, a clinical-stage antifungal compound with a novel mechanism of action, targeting invasive mold infections caused by A...
Treatment of invasive Aspergillus infections Acute invasive pulmonary aspergillosis (IPA) is the most frequent manifestation of systemic aspergillosis in neutropenic patients [162] with a fatality rate that ranges from 30 to 60 % [11, 116, 123]. Early treatment at first signs of infection is ...
Aspergillus fumigatus infection in the nasal cavity of a dog: its treatment with amphoptericin B. Vet Rec 1973; 92: 447-50... L Black,JP Nightingale - 《Veterinary Record》 被引量: 23发表: 1973年 Letter: Aspergillus infection of the nasal cavity of the dog Chandler EA: Aspergillus infect...
- 《Biotechnology for Biofuels》 被引量: 70发表: 2013年 The diagnosis and successful treatment of Aspergillus fumigatus infection of the frontal sinuses and nasal chambers of the dog Five cases of rhinitis and sinusitis in the dog are presented in which the invading organism was Aspergillus ...
The report emphasizes the need for further consideration of effective, long-term anti fungal prophylaxis and a careful balance between aggressive treatment for severe infection and antileukemic therapy.Keywords:Acute, Lymphoblastic, Leukemia, Aspergillus, Cerebral, AbscessA. Ng...
Aspergillus infection in lung transplant patients: incidence and prognosis. Eur J Clin Microbiol Infect Dis. 2007;26:879–86. 22. Valenza G, Tappe D, Turnwald D, et al. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst ...
Kitahara, M., Seth, V. K., Medoff, G., Kobayashi, G. S.Activity of amphotericin B, 5-fluorocytosine and rifampin against six clinical isolates ofAspergillus. Antimicrobial Agents and Chemotherapy 1976, 9: 915–919. Google Scholar Kitahara, M., Kobayashi, G. S., Medoff, G.Enhanced effic...
The response rate for evaluable patients with Candida spp was 65%, 38% for patients with Aspergillus spp, and 42% for patients with other or multiple fungal infections. In this patient population at high risk of nephrotoxicity due to concomitant cyclosporine and/or other nephrotoxic agents, ABCD...
Invasive Aspergillus infections and infection with other moulds than Aspergillus spp. do occur, but do not constitute a large proportion of these infections. As of today we have four classes of antifungal agents and seven drugs with different mechanisms of action are registered in Norway. Primary ...